|
Volumn 9, Issue 7, 2010, Pages 2152-
|
Variant isoforms of BCR-ABL1 in chronic myelogenous leukemia reflect alternative splicing of ABL1 in normal tissue - Letter
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
IMATINIB;
ISOPROTEIN;
PROTEIN TYROSINE KINASE INHIBITOR;
ABELSON KINASE;
ANTINEOPLASTIC AGENT;
ALTERNATIVE RNA SPLICING;
CHRONIC MYELOID LEUKEMIA;
EXON;
GENE DELETION;
GENE SEQUENCE;
GENETIC TRANSCRIPTION;
GENETIC VARIABILITY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TREATMENT RESPONSE;
DRUG RESISTANCE;
GENETICS;
MUTATION;
ALTERNATIVE SPLICING;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
EXONS;
FUSION PROTEINS, BCR-ABL;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MUTATION;
PROTO-ONCOGENE PROTEINS C-ABL;
SEQUENCE DELETION;
|
EID: 77954570602
PISSN: 15357163
EISSN: 15388514
Source Type: Journal
DOI: 10.1158/1535-7163.MCT-10-0311 Document Type: Letter |
Times cited : (5)
|
References (6)
|